Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenue:        
Total revenue $ 14,471 $ 11,873 $ 27,652 $ 22,471
Costs and expenses:        
Cost of revenue 12,460 8,441 24,185 15,870
Selling, general and administrative 19,079 2,828 29,199 5,808
Research and development 3,975 2,128 6,594 3,375
Gain (loss) on sale of assets 33 (9) 33 (9)
Total costs and expenses 35,547 13,388 60,011 25,044
Loss from operations (21,076) (1,515) (32,359) (2,573)
Nonoperating income (expense):        
Gain (loss) on remeasurement of private warrants 58,740 0 (21,957) 0
Interest expense, net (222) (384) (422) (1,097)
Gain on forgiveness of debt 1,776 0 1,776 0
Loss on debt extinguishment 0 0 (2,604) 0
Other income (expense), net 30 99 80 189
Total nonoperating income (expenses) 60,324 (285) (23,127) (908)
Income (loss) before income taxes 39,248 (1,800) (55,486) (3,481)
Income tax expense 0 0 0 0
Net income (loss) $ 39,248 $ (1,800) $ (55,486) $ (3,481)
Net loss per share:        
Basic net income (loss) per share $ 0.44 $ (0.06) $ (0.64) $ (0.12)
Diluted net income (loss) per share $ 0.39 $ (0.06) $ (0.64) $ (0.12)
Weighted average number of shares used to compute basic net income (loss) per share 88,806,086 29,005,309 86,760,615 28,386,948
Dilutive effect of warrants and stock options 12,718,858 0 0 0
Weighted average number of shares used to compute diluted net income (loss) per share 101,524,944 29,005,309 86,760,615 28,386,948
Products        
Revenue:        
Total revenue $ 11,294 $ 10,576 $ 22,318 $ 19,755
Services        
Revenue:        
Total revenue $ 3,177 $ 1,297 $ 5,334 $ 2,716